Source link : https://www.newshealth.biz/health-news/combo-therapy-for-cidp-benefits-despite-clotting-risk/
MONTREAL — A combination of intravenous immunoglobulin (IVIg) and methylprednisolone (MP) was associated with greater improvement in disability in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) than immunoglobulin alone. The OPTIC trial was terminated early when four thromboembolic events prompted unblinding of the multicenter, randomized, double-blind, placebo-controlled trial, revealing all four events occurred in the […]
Author : News Health
Publish date : 2024-07-03 14:07:12
Copyright for syndicated content belongs to the linked Source.
Categories